Showing posts with label NellOne Therapeutics. Show all posts
Showing posts with label NellOne Therapeutics. Show all posts

Friday, January 29, 2010

Thursday, January 28, 2010

NellOne Therapeutics licenses from UT-Battelle

Knoxville-based NellOne Therapeutics has licensed patents covering inventions based on the Nell-1 gene. The IP is driving protein therapy treatment now under development and takes advantage of the gene's cell-signaling pathway, which controls tissue growth and maturation in mammalian organs. It could mean restorative therapies for hearts and other muscles. Our story's here.